| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |